Paion AG

Paion AG

PAIOF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$410.19K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Paion AGPaion AG-0.6-864%--6.9

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$410,188.00
Enterprise Value$17.01 Million
Earnings per Share$-0.08
Beta4.14
Outstanding Shares7,134,000

Return

Return on Equity864.42%ROE
Return on Assets-82.21%
Return on Invested Capital-98.48%

Valuation & Multiples

P/E Ratio-0.58P/E Ratio
PEG-3.51PEG
Price to Sales0.03Price to Sales
Price to Book Ratio-0.05Price to Book Ratio
Enterprise Value to Revenue1.04
Enterprise Value to EBIT-1.12
Enterprise Value to Net Income-1
Total Debt to Enterprise1.25
Debt to Equity-6.93Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 2, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Paion AG

15,166 employees
CEO: Jay Pestrichelli

Paion AG operates as a specialized pharmaceutical entity, concentrating its efforts on creating and selling groundbreaking treatments within the realms of anesthesia, intensive care, and critical care medicine. The company places particu...